Pharmaceutical Industry
- All
- News
- Videos
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
Pharma OTT Release: Nivin Pauly Starrer to Stream on Disney+ Hotstar
Pharma, starring Nivin Pauly in his digital debut, had its world premiere at the 55th International Film Festival of India (IFFI) on November 27, 2024. Directed by P. R. Arun, the series has been well-received for its exploration of the pharmaceutical industry and the challenges faced by its protagonist. Streaming on Disney+ Hotstar is anticipated ...
-
Kiran Mazumdar-Shaw Opposes Karnataka's Job Quota Bill, Minister Responds
Kiran Mazumdar-Shaw, the founder of pharmaceutical giant Biocon, on Wednesday opposed the proposal to reserve private jobs for local hires in Karnataka, which houses the country's information technology hub Bengaluru.
-
Tax Benefits, Intellectual Property Rights On Pharma Industry's Budget Wishlist
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies.
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
"Avoid Eating Poppy Seeds": Pentagon Warns US Soldiers
According to the memo, the seeds come from poppy plants, a commercial crop cultivated by the drug and food industries for pharmaceuticals and spices. The seeds can become contaminated with morphine and codeine during the harvest.
-
As Surplus Grows, France To Turn Leftover Wine Into Industrial Alcohol
France plans to spend millions of euros to turn wine into industrial alcohol for pharmaceuticals and cosmetics to drain a massive surplus, the agriculture ministry has said.
-
Fire Breaks Out At Pharmaceutical Company In Gujarat
A fire broke out in a pharmaceutical company in Kalol Gujarat Industrial Development Corporation (GIDC) on Sunday and about 10 firefighters have been deployed to put out the blaze.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Not Without India: World's Pharmacy Gears Up For COVID-19 Vaccine Race
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
"10 Covid Vaccines Likely By 2021 Summer": Global Pharma Group Head
Ten COVID-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
Pharma OTT Release: Nivin Pauly Starrer to Stream on Disney+ Hotstar
Pharma, starring Nivin Pauly in his digital debut, had its world premiere at the 55th International Film Festival of India (IFFI) on November 27, 2024. Directed by P. R. Arun, the series has been well-received for its exploration of the pharmaceutical industry and the challenges faced by its protagonist. Streaming on Disney+ Hotstar is anticipated ...
-
Kiran Mazumdar-Shaw Opposes Karnataka's Job Quota Bill, Minister Responds
Kiran Mazumdar-Shaw, the founder of pharmaceutical giant Biocon, on Wednesday opposed the proposal to reserve private jobs for local hires in Karnataka, which houses the country's information technology hub Bengaluru.
-
Tax Benefits, Intellectual Property Rights On Pharma Industry's Budget Wishlist
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies.
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
"Avoid Eating Poppy Seeds": Pentagon Warns US Soldiers
According to the memo, the seeds come from poppy plants, a commercial crop cultivated by the drug and food industries for pharmaceuticals and spices. The seeds can become contaminated with morphine and codeine during the harvest.
-
As Surplus Grows, France To Turn Leftover Wine Into Industrial Alcohol
France plans to spend millions of euros to turn wine into industrial alcohol for pharmaceuticals and cosmetics to drain a massive surplus, the agriculture ministry has said.
-
Fire Breaks Out At Pharmaceutical Company In Gujarat
A fire broke out in a pharmaceutical company in Kalol Gujarat Industrial Development Corporation (GIDC) on Sunday and about 10 firefighters have been deployed to put out the blaze.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Not Without India: World's Pharmacy Gears Up For COVID-19 Vaccine Race
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
"10 Covid Vaccines Likely By 2021 Summer": Global Pharma Group Head
Ten COVID-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
